Area of research
Psychiatry and Mental health · Physiology
Research interest
Research interests include Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Health, Environment, Cognitive Aging, and Functional Brain Connectivity Studies.
Relationships of PGRN with sTREM2 in AD continuum and non-AD pathophysiology and their reciprocal roles in modulating amyloid pathology: two population-based study
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials
The Alzheimer's Disease Neuroimaging Initiative‐4 (ADNI‐4) Engagement Core: A culturally informed, community‐engaged research (CI‐CER) model to advance brain health equity
The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research
Enhancing cognitive performance prediction by white matter hyperintensity connectivity assessment
The effect of study partner characteristics on the reporting of neuropsychiatric symptoms across the neurocognitive spectrum
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease
Determinants of cognitive and brain resilience to tau pathology: a longitudinal analysis
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening
Increasing participant diversity in AD research: Plans for digital screening, blood testing, and a community‐engaged approach in the Alzheimer's Disease Neuroimaging Initiative 4
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Improving generalizability and study design of Alzheimer's disease cohort studies in the United States by including under‐represented populations
The role of dyadic cognitive report and subjective cognitive decline in early ADRD clinical research and trials: Current knowledge, gaps, and recommendations
The Polygenic Risk Score Knowledge Base offers a centralized online repository for calculating and contextualizing polygenic risk scores
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data
Cognitive profile of mild behavioral impairment in Brain Health Registry participants
Late contributions of repetitive head impacts and TBI to depression symptoms and cognition
The Brain Health Registry: An internet‐based platform for recruitment, assessment, and longitudinal monitoring of participants for neuroscience studies
Unsupervised online neuropsychological test performance for individuals with mild cognitive impairment and dementia: Results from the Brain Health Registry
Assessing risk for preclinical β‐amyloid pathology with <i>APOE</i>, cognitive, and demographic information
Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2
Emerging β-Amyloid Pathology and Accelerated Cortical Atrophy
CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders
Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults